Dr David Dodwell
David Dodwell
BSc, MD, FRCP, FRCR
Senior Clinical Research Fellow
David is a senior breast oncologist with a number of research and governance interests.
He is the lead oncologist on the Sloane and NHS breast screening audits and co-lead for the national audits in primary and metastatic breast cancer.
Recent publications
-
Survival following adjuvant trastuzumab-based treatment among older patients with HER2-positive early invasive breast cancer: A national population-based cohort study using routine data.
Journal article
Gannon MR. et al, (2024), Eur J Cancer, 211
-
Locoregional recurrence in studies of primary systemic therapy in early invasive breast cancer
Journal article
Chen L. et al, (2024), The Breast, 103791 - 103791
-
Exploring locoregional treatment reporting in neoadjuvant systemic breast cancer treatment studies: A systematic review.
Journal article
Jiang M. et al, (2024), Eur J Surg Oncol, 50
-
Survival outcomes after breast cancer surgery among older women with early invasive breast cancer in England: population-based cohort study.
Journal article
Miller K. et al, (2024), BJS Open, 8
-
TEMPORARY REMOVAL: Estimated doses to the heart, lungs and oesophagus and risks from typical UK radiotherapy for early breast cancer during 2015-2023
Journal article
Holt F. et al, (2024), Clinical Oncology